Research Interest

RESEARCH HIGHLIGHTS

Currently as the CSO, Oncology at Natera, Dr. Lin's focus in using blood-based DNA technologies to detect, diagnosis, and monitor different types of cancers - earlier and more accurately, with greater sensitivity and specificity.

Experience

BOARD

MD/PhD

Publications

Dr. Lin has published over 70 papers in the some of most prestigious scientific journals, including being featured on the cover of both Science and Nature - the top two academic journals.